These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28292536)

  • 41. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
    Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
    Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
    Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.
    Kikuchi I; Kase S; Ishijima K; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2271-2276. PubMed ID: 28752368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of mitomycin C for corneal-conjunctival intraepithelial neoplasia: management options--case reports].
    de Figueirêdo RS; de Figueirêdo ES
    Arq Bras Oftalmol; 2006; 69(3):407-11. PubMed ID: 16936968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corneal melt in conjunctival intraepithelial neoplasia.
    Warren N; Mercer RN; Haddad J; Magrath G; Rocha KM
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100689. PubMed ID: 32426552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops].
    Mata E; Conesa E; Castro M; Martínez L; de Pablo C; González ML
    Arch Soc Esp Oftalmol; 2014 Jul; 89(7):293-6. PubMed ID: 24269461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
    Kase S; Ishijima K; Noda M; Ishida S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular surface toxicity associated with topical interferon alpha-2b.
    Aldave AJ; Nguyen A
    Br J Ophthalmol; 2007 Aug; 91(8):1087-8. PubMed ID: 17638822
    [No Abstract]   [Full Text] [Related]  

  • 51. The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size.
    Vilaltella M; Huerva V
    Arq Bras Oftalmol; 2021; 85(2):109-114. PubMed ID: 34431893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of conjunctival papillomata with topical interferon Alfa-2b.
    Schechter BA; Rand WJ; Velazquez GE; Williams WD; Starasoler L
    Am J Ophthalmol; 2002 Aug; 134(2):268-70. PubMed ID: 12140037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon alpha for the treatment of melanocytic conjunctival lesions.
    Herold TR; Hintschich C
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):111-5. PubMed ID: 19756691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.
    Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL
    Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjunctival papillomatosis in children treated with co-adjuvant topical interferon alpha-2b.
    Rodríguez-Cabrera L; García-Regil P; Velasco-Levy A; Serna-Ojeda JC
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jul; 94(7):352-354. PubMed ID: 30424910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
    Shousha MA; Karp CL; Perez VL; Hoffmann R; Ventura R; Chang V; Dubovy SR; Wang J
    Ophthalmology; 2011 Aug; 118(8):1531-7. PubMed ID: 21507486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.